UBE2L3 expression in human gastric cancer and its clinical significance
Journal of Cancer Research and Clinical Oncology · 2024
DOI: 10.1007/s00432-024-05669-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Xiaoxia Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of the Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730030, China. Hauptthemen laut MEDLINE: Apoptosis, Cell Proliferation, Stomach Neoplasms, Ubiquitin-Conjugating Enzymes. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities of Lanzhou University, Medical Innovation and Development Project of Lanzhou University, Major Science and Technology Project of Gansu Province.
Abstract (Originalsprache)
Purpose
Gastric cancer (GC) is prevalent as one of the most common malignant tumors globally, with a particularly high incidence in China. The role of UBE2L3 in the initiation and progression of various cancers has been well documented, but its specific significance in GC is not yet fully elucidated. The objective of this study is to examine the expression and importance of UBE2L3 in human gastric cancer tissues.
Methods
Immunohistochemical staining and survival analysis were conducted on 125 cases of GC. Western blot and quantitative real-time polymerase chain reaction (qRT-PCR) were employed to assess the expression of UBE2L3 in GC cell lines. Cell lines with UBE2L3 knockdown and overexpression were cultured through lentivirus transfection and subsequently assessed using Western blot analysis. The involvement of UBE2L3 in the proliferation, invasion, and apoptosis of GC cells was confirmed through in vitro experiments, and its capacity to facilitate tumor growth was also validated in in vivo studies.
Results
The up-regulation of UBE2L3 expression was observed in GC, and its high expression was found to be significantly associated with the degree of differentiation (χ 2 = 6.153, P = 0.0131), TNM stage (χ 2 = 6.216, P = 0.0447), and poor overall survival. In vitro, UBE2L3 has been shown to enhance functions in GC cell lines, such as promoting proliferation and invasion, and inhibiting apoptosis. In vivo experiments have validated the role of UBE2L3 in promoting tumor growth.
Conclusions
The findings of our study demonstrate the significant involvement of UBE2L3 in the pathogenesis and advancement of gastric cancer, suggesting its potential as a therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of the Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730030, China.
- Key Laboratory of Digestive System Tumors of Gansu Province, Lanzhou, 730030, China.
- Department of Ophthalmology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730030, China.
- Department of Pneumology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730030, China.
- Department of General Surgery, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730030, China.
- Department of the Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730030, China. ery_zhaoyang@lzu.edu.cn.
Förderung
- Fundamental Research Funds for the Central Universities of Lanzhou University
- Medical Innovation and Development Project of Lanzhou University
- Major Science and Technology Project of Gansu Province
- Project of Gansu Provincial Department of Education
- Project of Gansu Provincial Development and Reform Commission
- Natural Science Foundation of Gansu Province
- Gansu key research and development program
- Scientific research training program for Cuiying students in the Second Hospital of Lanzhou University
Zitieren
APA
Zhang, X., Wei, Y., Wu, F., Li, M., Han, C., Huo, C., Li, Z., Tang, F., He, W., Zhao, Y., & Li, Y. (2024). UBE2L3 expression in human gastric cancer and its clinical significance. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05669-7
Vancouver
Zhang X, Wei Y, Wu F, Li M, Han C, Huo C, et al. UBE2L3 expression in human gastric cancer and its clinical significance. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05669-7
BibTeX
@article{Zhang2024,
author = {Zhang, Xiaoxia and Wei, Yujie and Wu, Fanqi and Li, Mei and Han, Cong and Huo, Chengdong and Li, Zhi and Tang, Futian and He, Wenting and Zhao, Yang and Li, Yumin},
title = {UBE2L3 expression in human gastric cancer and its clinical significance},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
doi = {10.1007/s00432-024-05669-7}
}
EUVIMED